Abvc Biopharma (ABVC) Shares Outstanding (Entity) (2010 - 2026)
Abvc Biopharma (ABVC) reported Shares Outstanding (Entity) of 25.77 million for Q2 2026, up 31.9% from 19.53 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma posted Shares Outstanding (Entity) of 20.11 million, up 45.0% from FY2024.
- Shares Outstanding (Entity) has increased for six consecutive years, with a five-year compound annual growth rate of 59.1% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 13.87 million in FY2024 (+219.9%), 4.34 million in FY2023 (+32.0%), 3.29 million in FY2022 (+13.6%) and 2.89 million in FY2021 (+46.7%).
- Year over year, Shares Outstanding (Entity) has now increased in each of the last 26 quarters, with growth averaging 90.5% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 2.4% (Q2 2023) to 264.3% (Q2 2024).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.77 million (Q1 2026), 20.11 million (Q4 2025) and 24.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Abvc Biopharma | 27.36 Mn | 26.06 Mn | - | 25.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.77 Mn |
| Mar 31, 2026 | 25.77 Mn |
| Dec 31, 2025 | 20.11 Mn |
| Sep 30, 2025 | 24.19 Mn |
| Jun 30, 2025 | 19.53 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 13.87 Mn |
| Sep 30, 2024 | 12.71 Mn |
| Jun 30, 2024 | 12.05 Mn |
| Mar 31, 2024 | 10.70 Mn |
| Dec 31, 2023 | 4.34 Mn |
| Sep 30, 2023 | 4.82 Mn |
| Jun 30, 2023 | 3.31 Mn |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 3.29 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.79 Mn |
API Access
Abvc Biopharma Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();